Prudential Financial Inc Coherus Bio Sciences, Inc. Transaction History
Prudential Financial Inc
- $74.4 Billion
- Q2 2025
A detailed history of Prudential Financial Inc transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 14,980 shares of CHRS stock, worth $20,223. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,980Holding current value
$20,223% of portfolio
0.0%Shares
16 transactions
Others Institutions Holding CHRS
# of Institutions
120Shares Held
56.1MCall Options Held
89.3KPut Options Held
31K-
Black Rock Inc. New York, NY11.8MShares$15.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.3MShares$13.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA5.1MShares$6.88 Million0.22% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY3.04MShares$4.1 Million0.09% of portfolio
-
Geode Capital Management, LLC Boston, MA2.74MShares$3.7 Million0.0% of portfolio
About Coherus BioSciences, Inc.
- Ticker CHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,724,600
- Market Cap $105M
- Description
- Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...